Denali Therapeutics
Price & Volume
Stats
See moreOpen | $14.84 |
Previous Close | $14.76 |
Day Range | $14.34-$14.84 |
52W Range | $14.01-$33.33 |
Market Cap | $2.1B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$396.4M |
Diluted EPS | -$2.57 |
News
See moreYahoo Finance • 26 days ago
Denali Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Yahoo Finance • 2 months ago
Denali Therapeutics Announces Primary Analysis and Long-Term Follow-Up of Phase 1/2 Study in Hunter Syndrome (MPS II) with Tividenofusp Alfa
Yahoo Finance • last year
Denali Therapeutics Inc (DNLI) Reports Full Year and Q4 2023 Financial Results
Yahoo Finance • last year
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
About
CEO | Dr. Ryan J. Watts Ph.D. |
CFO | Dr. Alexander O. Schuth M.D. |
Address | 161 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 422 |
